Arghami Arman, Dy Benzon M, Bingener Juliane, Osborn John, Richards Melanie L
Department of Surgery, Mayo Clinic, Rochester MN.
JSLS. 2015 Jan-Mar;19(1):e2014.00218. doi: 10.4293/JSLS.2014.00218.
The introduction of robotic surgery offers patients and surgeons new options for adrenalectomy. Whereas multiport adrenalectomies have been safely performed using the robot, we describe our experience with the novel technique of single-port robotic-assisted adrenalectomy.
We performed a matched-cohort study comparing 16 single-port robotic-assisted adrenalectomies with 16 patients from a pool of 148 laparoscopic adrenalectomies, matched for age, gender, operative side, pathology, and body mass index. All were operated on by 1 surgeon.
The pathology included aldosteronoma in 44% of patients, adrenocorticotropic hormone-dependent Cushing syndrome (bilateral adrenalectomy) in 19%, pheochromocytoma in 13%, and other pathology in 24%. The operative time was 183 ± 33 minutes for single-port robotic-assisted adrenalectomy and 173 ± 40 minutes for laparoscopic adrenalectomy (P = .58). The total time in the operating room was 246 ± 33 minutes for single-port robotic-assisted adrenalectomy and 240 ± 39 minutes for laparoscopic adrenalectomy (P = .57). There was 1 conversion to open adrenalectomy (6%) in each group, both because of bleeding on the right side during bilateral adrenalectomy. Two right-sided single-port robotic-assisted adrenalectomy patients required conversion to laparoscopic adrenalectomy, one because of poor visualization. There were no deaths. Complications occurred in 2 patients in each group (intensive care unit admission, prolonged ileus). Both groups had similar pain scores (mean of 3.7 on a scale from 1 to 10) on postoperative day 1, and patients in the single-port robotic-assisted adrenalectomy group used less narcotic pain medication in the first 24 hours after surgery (43 mg vs 84 mg in laparoscopic adrenalectomy group, P < .001). The differences between the single-port robotic-assisted adrenalectomy group and laparoscopic adrenalectomy group in length of stay (2.3 ± 0.5 days vs 3.1 ± 0.9 days, P = .23), percentage of patients discharged on postoperative day 1 (56% vs 31%, P = .10), and hospital cost (16% lower in single-port robotic-assisted adrenalectomy group, P = .17) did not reach statistical significance.
Single-port robotic adrenalectomy is feasible; patients require less narcotic pain medication whereas costs appear equivalent compared with laparoscopic adrenalectomy.
机器人手术的引入为肾上腺切除术的患者和外科医生提供了新的选择。虽然多端口肾上腺切除术已通过机器人安全实施,但我们描述了单端口机器人辅助肾上腺切除术这项新技术的经验。
我们进行了一项匹配队列研究,将16例单端口机器人辅助肾上腺切除术与148例腹腔镜肾上腺切除术中选取的16例患者进行匹配,匹配因素包括年龄、性别、手术侧别、病理类型和体重指数。所有手术均由1名外科医生完成。
病理类型包括醛固酮瘤患者占44%,促肾上腺皮质激素依赖性库欣综合征(双侧肾上腺切除术)患者占19%,嗜铬细胞瘤患者占13%,其他病理类型患者占24%。单端口机器人辅助肾上腺切除术的手术时间为183±33分钟,腹腔镜肾上腺切除术的手术时间为173±40分钟(P = 0.58)。单端口机器人辅助肾上腺切除术的手术室总时长为246±33分钟,腹腔镜肾上腺切除术的手术室总时长为240±39分钟(P = 0.57)。每组各有1例转为开放性肾上腺切除术(6%),均是由于双侧肾上腺切除术时右侧出血。2例右侧单端口机器人辅助肾上腺切除术患者需要转为腹腔镜肾上腺切除术,1例是因为视野不佳。无死亡病例。每组各有2例患者发生并发症(入住重症监护病房、肠梗阻延长)。两组术后第1天的疼痛评分相似(1至10分制下平均为3.7分),单端口机器人辅助肾上腺切除术组患者在术后头24小时使用较少的麻醉性镇痛药(43毫克,而腹腔镜肾上腺切除术组为84毫克,P < 0.001)。单端口机器人辅助肾上腺切除术组与腹腔镜肾上腺切除术组在住院时间(2.3±0.5天对3.1±0.9天,P = 0.23)、术后第1天出院患者百分比(56%对31%,P = 0.10)以及住院费用(单端口机器人辅助肾上腺切除术组低16%,P = 0.17)方面的差异未达到统计学意义。
单端口机器人肾上腺切除术是可行的;与腹腔镜肾上腺切除术相比,患者需要较少的麻醉性镇痛药,而费用似乎相当。